Effect of Ethanolic extract of Boerhhvia diffusa against Doxorubicin induced Nephrotoxicity in Albino rats
Abstract
Anthracycline derivative i.e. doxorubicin (Dox) has proven efficacy in several malignancies such as breast cancer, Hodgkin and non-Hodgkin lymphoma, acute leukemia, lung, thyroid and ovarian cancer. The clinical usefulness is restricted due to its cardiotoxicity and nephrotoxicity. Boerhaavia diffusa belongs to family Nyctaginaceae and in Ayurveda, it is claimed for use in renal disorders.
The main phytoconstituents of the plant are alkaloids, terpenoids, tannins, glycosides, flavonoids, phenolic compounds. To investigate the ameliorative role of ethanolic extract of petals of B. diffusa in doxorubicin-induced nephrotoxicity in rats. Nephrotoxicity was produced by administering doxorubicin (2.5 mg/kg b.w., i.p. alternate day) in six equal injections for two weeks to become cumulatively 15 mg/kg. Low (LEBD–100 mg/kg p.o.)
and high (HEBD–200 mg/kg p.o.) dose of ethanolic extract of Boerhhvia diffusa was administered as a pretreatment before doxorubicin administration. The general parameters such as body weight, food, and water intake were measured throughout the study period. Serum markers such as blood urea nitrogen (BUN), serum creatinine and albumin were measured. Antioxidant enzymes such as glutathione (GSH), malondialdehyde (MDA), catalase (CAT), and superoxide dismutase (SOD) were monitored after the last dose. Histopathological studies were also carried out to evaluate nephrotoxicity. The repeated administration of doxorubicin produces several morphological changes, decreased body weight, food, and water consumption. Serum markers such as BUN and serum creatinine were increased and albumin levels decreased. The GSH, SOD, and CAT were decreased, whereas the MDA level was increased, and deteriorating changes in the histological architecture of kidney tissue were observed. The HEBD pretreated groups dose-dependently increased body weight and food and water intake (p < 0.01 and p < 0.05), whereas LEBD does not show any significant changes. The LEBD and HEBD pretreated groups decreased the BUN (p < 0.05 and p < 0.01) and serum creatinine (p < 0.05 and p < 0.05) and increased in the albumin (p < 0.05 and p < 0.05) levels, respectively. The pretreatment with LEBD and HEBD increased the level of the antioxidant enzyme i.e., GSH (p < 0.05 and p < 0.01), SOD (p < 0.05 and p < 0.01), CAT (p < 0.05 and p < 0.01) and decreased the MDA level (p < 0.05 and p < 0.01) respectively. Histopathological studies showed that the pretreatment with LEBD and HEBD groups minimized the tubular damage and reduced the inflammation as compared to doxorubicin-treated group. The biochemical and histopathological results data support the nephroprotective effect of ethanolic extract of B. diffusa, which might be credited to its antioxidant property.
Keywords:
Doxorubicin, Boerhhvia diffusa, Nephrotoxicity, histopathologyDOI
https://doi.org/10.25004/IJPSDR.2021.130602References
Blum RH. Carter SK. Adriamycin. A new anticancer drug with significant clinical activity. Ann Intern Medicine. 1974;80(2): 249-259.
Gillick J, Giles S, Bannigan J, Puri P. Cell death in the early adriamycin rat model. Pediatr. Surg. Int. 2002; 18:576-580.
Yilmaz S, Atessahin A, Sahna E, Karahan I, Ozer S. Protective effect of lycopene on adriamycin-induced cardiotoxicity and nephrotoxicity. Toxicology. 2006; 218:164–171.
Saad SY, Najjar TA, Al-Rikabi AC. The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacol. Res. 2001;43:211–218.
Doroshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 1983;43(2):460-472.
Rajaprabhu D, Rajesh R, Jeyakumar R, Buddhan S, Ganesan B, AnandanR. Protective effect of Picrorhizakurroaon antioxidant defense status inadriamycin-induced cardiomyopathy in rats. J Med Plants Res. 2007; 1(November):80-85.
Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. Faseb J. 1990; 4(13):3076-3086.
Gille L, Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med. 1997; 23(5): 775-782.
Lahoti TS, Patel D, Thekkemadom V, Beckett R, Ray SD. Doxorubicin-induced in vivo nephrotoxicity involves oxidative stress-mediated multiple pro- and anti-apoptotic signaling pathways. Curr Neurovasc Res.. 2012; 9(4):282-295.
Vikrant A, Gupta KV. Chemistry and Pharmacology of plant cardioprotectives: A Review. Int J Pharm Sci Res. 2011; 2(5):1156– 1167.
Tilak-jain JA, Paul T, Devasagayam A. Cardioprotective and Other Beneficial Effects of Some Indian Medicinal Plants. J Clin Biochem Nutr. 2006; 38(January):9-18.
Mohan M, Kamble S, Gadhi P, Kasture S. Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food Chem Toxicol. 2010; 48(1):436-440.
Kirtikar KR. Basu BD. Indian Medicinal Plants. Periodical Experts Book Agency, Delhi.1991.
The Wealth of India. Raw Materials Vol 2B & IX. Publication and Information Directorate. CSIR. New-Delhi. 2003.
Hiruma CA, Gracioso JS, Bighetti EJ, Germonsen RL, Souza B. The juice of fresh leaves of Boerhaavia diffusa L. (Nyctaginaceae) markedly reduces pain in mice. J Ethnopharmacol. 2000; 71(1-2): 267-274.
Meera S, Mustafa SS. Anti-stress, Adaptogenic and Immuno potentiating activity of Roots of Boerhaavia diffusa in mice. Int J Pharmacology. 2007; 3(5):416-420.
Tolulope OM, Afolabi C, Adebayo A. Antioxidant and Hepatoprotective property of leaf extracts of Boerhaavia diffusa Linn against acetaminophen induced Liver damage in rats. Food Chem Toxicol. 2010; 48:2200-2205.
Chandan BK, Sharma AK, Anand KK. Boerhaavia diffusa: A study of its hepato-protective activity. J Ethanopharmacol. 1991; 31(3): 299-307.
Mandeep K, Rajesh G. Anti-convulsant activity of Boerhaavia diffusa: Plausible role of Calcium Channel Antagonism. Evidence-based Complementary and Al¬ternative Medicine. 2011; article ID 310420.
Parasuraman S, Kumar E, Kumar A, Emerson S. Free radical scavenging property and diuretic effect of triglize, a polyherbal formulation in experimental models. J Pharmacol Pharmacother. 2010;1(1):38-41.
Mahesh A, Kumar H, Ranganath MK, Devkar RA. Detail Study on Boerhaavia diffusa Plant for its Medicinal Importance-A Review. Res J Pharm Sci J Pharm Sci. 2012;1(1):28–36.
Liao CH, Ho CT, Lin JK. Effects of garcinol on free radical generation and NO production in embryonic rat cortical neurons and astrocytes. Biochem Biophys Res Commun. 2005; 329(4):1306-1314.
Grover J. Hepato and cardio protective action of tulsi (ocimum sanctum Linn). Eur J Pharmacol 1990; 183(3):872.
Vaidya AD, Devasagayam TP. Current status of herbal drugs in India: an overview. J Clin Biochem Nutr. 2007; 41(1):1-11.
Gupta S, Sharma M, Kishore K, Arya D. Ocimum santum provides cardiacprotection in isoproternol induced myocardial infarction in rats. J Mol Cell Cardiol. 2001; 33:A42.
Harborne J. Phytochemical Methods, A guide to modern techniques of plant analysis. 3rd ed. London (UK): Chapman and Hall; 2007;16-32.
OECD Guidelines 423 for testing of chemicals. 2001;1-26.
Mansour MA, El-Kashef HA, Al-Shabanah OA. Effect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacol Res. 1999; 39(3):233-237.
Ellman GL. Tissue sulfhydryl groups. Archives of biochemistry and biophysics. 1959 May 1;82(1):70-77.
Niehaus Jr WG, Samuelsson B. Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. European journal of biochemistry. 1968 Oct;6(1):126-130.
Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys. 1984; 21(2):130-142.
Sinha AK. Colorimetric assay of catalase. Anal Biochem. 1972; 47(2):389-394.
G Gilliam LAA, St Clair DK. Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress. Antioxid Redox Signal. 2011; 15(9):2543–2563.
Refaie MM, Amin EF, El-Tahawy NF, Abdelrahman AM. Possible protective effect of diacerein on doxorubicin-induced nephrotoxicity in rats. Journal of toxicology. 2016 Jan 20;2016.
Rashid S, Ali N, Nafees S, Ahmad ST, Arjumand W, Hasan SK, Sultana S. Alleviation of doxorubicin-induced nephrotoxicity and hepatotoxicity by chrysin in Wistar rats. Toxicol Mech Methods. 2013; 23(5):337-345.
Mohan M, Kamble S, Gadhi P, Kasture S. Protective effect of Solanum torvum on doxorubicin-induced nephrotoxicity in rats. Food Chem Toxicol. 2010; 48:436-440.
Ajith TA, Aswathy MS, Hema U. Protective effect of Zingiber officinale roscoe against anticancer drug doxorubicin-induced acute nephrotoxicity. Food Chem Toxicol. 2008; 46:3178-3181.
Rashikh A, Pillai KK, Ahmad SJ, Akhtar M, Najmi AK. Aliskiren alleviates doxorubicin-induced nephrotoxicity by inhibiting oxidative stress and podocyte injury. Journal of the renin-angiotensin-aldosterone system. 2013;14(1):14-22.
Mansour MA, El-Kashef HA, AL-SHABANAH OA. Ef fect of captopril on doxorubicin-induced nephrotoxicity in normal rats. Pharmacological research. 1999 Mar 1;39(3):233-237.
Koti BC, Nagathan S, Vishwanathswamy A, Gadad PC, Thippeswamy A. Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: A biochemical, electrocardiographic, and histopathological study. Pharmacogn Mag. 2013; 9(34):176-181.
Kumar D, Kirshenbaum LA, Li T, Danelisen I, Singal PK. Apoptosis in adriamycin cardiomyopathy and its modulation by probucol. Antioxidants and Redox Signaling. 2001 Feb 1;3(1):135-145.
Hai-Xia Liu, Jin Li, Qi-Xiong Li. Therapeutic effect of valsartan against doxorubicin-induced renal toxicity in rats. Iran J Basic Med Sci. 2019; 22(3):251-254.
Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney international. 1989;35(5):1093-1106.
Deman A, Ceyssens B, Pauwels M, Zhang J, Houte KV, Verbeelen D, et al. Altered antioxidant defence in a mouse adriamycin model of glomerulo sclerosis. Nephrol Dial Transplant. 2001; 16(1):147–145.
Dobashi K, Ghosh B, Orak JK, Singh I, Singh AK. Kidney ischemia-reperfusion: modulation of antioxidant defenses. Mol Cell Biochem. 2000; 205:1-11.
Bray TM, Taylor CG. Tissue glutathione, nutrition, and oxidative stress. Can J Physiol Pharmacol. 1993; 71(9):746-751.
Gaweł S, Wardas M, Niedworok E, Wardas P. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek. 2004;57(9-10):453-455.
Ayla S, Seckin I, Tanriverdi G, Cengiz M, Eser M, Soner BC, Oktem G. Doxorubicin induced nephrotoxicity: protective effect of nicotinamide. International journal of cell biology. 2011 Jun 16;2011.
Published
Abstract Display: 642 
PDF Downloads: 556 
